← Every company

Fate Therapeutics Inc SEC Filings

What Fate Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

FATE overview →
Filings on file
130
since Nov 7, 2016
Warning signs
1
latest Apr 19, 2023
Last results
Aug 13, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 13, 2026
Quarterly report
10-Q
Read ↗
Aug 13, 2026
Results announced
8-K
Read ↗
Jun 15, 2026
Executive or director changeShareholder vote
8-K
Read ↗
May 13, 2026
Quarterly report
10-Q
Read ↗
May 13, 2026
Results announced
8-K
Read ↗
Feb 26, 2026
Annual report
10-K
Read ↗
Feb 26, 2026
Results announced
8-K
Read ↗
Nov 13, 2025
Quarterly report
10-Q
Read ↗
Nov 13, 2025
Results announced
8-K
Read ↗
Oct 14, 2025
Executive or director change
8-K
Read ↗
Aug 12, 2025
Quarterly report
10-Q
Read ↗
Aug 12, 2025
Results announcedRestructuring
8-K
Read ↗
Jun 17, 2025
Shareholder vote
8-K/A
Read ↗
May 30, 2025
Executive or director changeShareholder vote
8-K
Read ↗
May 13, 2025
Quarterly report
10-Q
Read ↗
May 13, 2025
Results announced
8-K
Read ↗
Mar 5, 2025
Annual report
10-K
Read ↗
Mar 5, 2025
Results announced
8-K
Read ↗
Jan 6, 2025
Executive or director change
8-K
Read ↗
Nov 29, 2024
Executive or director change
8-K
Read ↗
Nov 12, 2024
Quarterly report
10-Q
Read ↗
Nov 12, 2024
Results announced
8-K
Read ↗
Aug 30, 2024
Executive or director changeMaterial agreement
8-K
Read ↗
Aug 13, 2024
Quarterly report
10-Q
Read ↗
Aug 13, 2024
Results announced
8-K
Read ↗
Jul 31, 2024
Executive or director change
8-K
Read ↗
Jun 7, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 31, 2024
Executive or director change
8-K
Read ↗
May 9, 2024
Quarterly report
10-Q
Read ↗
May 9, 2024
Results announced
8-K
Read ↗
Mar 21, 2024
Material agreementUnregistered share sale
8-K
Read ↗
Feb 26, 2024
Annual report
10-K
Read ↗
Feb 26, 2024
Results announced
8-K
Read ↗
Nov 8, 2023
Material agreement
8-K
Read ↗
Nov 8, 2023
Quarterly report
10-Q
Read ↗
Nov 8, 2023
Results announced
8-K
Read ↗
Aug 8, 2023
Quarterly report
10-Q
Read ↗
Aug 8, 2023
Results announced
8-K
Read ↗
Jun 9, 2023
Shareholder vote
8-K
Read ↗
Jun 8, 2023
Executive or director change
8-K
Read ↗
May 3, 2023
Quarterly report
10-Q
Read ↗
May 3, 2023
Results announced
8-K
Read ↗
Apr 19, 2023
Delisting notice or listing transfer
8-K
Read ↗
Feb 28, 2023
Annual report
10-K
Read ↗
Feb 28, 2023
Results announced
8-K
Read ↗
Jan 5, 2023
Executive or director changeRestructuringMaterial agreement
8-K
Read ↗
Nov 7, 2022
Material agreement
8-K
Read ↗
Nov 3, 2022
Quarterly report
10-Q
Read ↗
Nov 3, 2022
Results announced
8-K
Read ↗
Aug 3, 2022
Quarterly report
10-Q
Read ↗
Aug 3, 2022
Results announced
8-K
Read ↗
Jun 30, 2022
Material agreement
8-K
Read ↗
Jun 13, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 4, 2022
Quarterly report
10-Q
Read ↗
May 4, 2022
Results announced
8-K
Read ↗
Feb 28, 2022
Annual report
10-K
Read ↗
Feb 28, 2022
Results announced
8-K
Read ↗
Nov 4, 2021
Material agreement
8-K
Read ↗
Nov 4, 2021
Quarterly report
10-Q
Read ↗
Nov 4, 2021
Results announced
8-K
Read ↗
Aug 4, 2021
Quarterly report
10-Q
Read ↗
Aug 4, 2021
Results announced
8-K
Read ↗
Aug 4, 2021
Executive or director change
8-K
Read ↗
Jun 7, 2021
Shareholder vote
8-K
Read ↗
May 5, 2021
Quarterly report
10-Q
Read ↗
May 5, 2021
Results announced
8-K
Read ↗
Mar 25, 2021
Executive or director change
8-K
Read ↗
Feb 24, 2021
Annual report
10-K
Read ↗
Feb 24, 2021
Results announced
8-K
Read ↗
Jan 8, 2021
Material agreement
8-K
Read ↗
Nov 5, 2020
Quarterly report
10-Q
Read ↗
Nov 5, 2020
Results announced
8-K
Read ↗
Aug 19, 2020
Executive or director change
8-K
Read ↗
Aug 5, 2020
Quarterly report
10-Q
Read ↗
Aug 5, 2020
Results announced
8-K
Read ↗
Jun 10, 2020
Material agreementUnregistered share sale
8-K
Read ↗
May 11, 2020
Quarterly report
10-Q
Read ↗
May 11, 2020
Results announced
8-K
Read ↗
May 5, 2020
Executive or director changeShareholder vote
8-K
Read ↗
Apr 2, 2020
Material agreementUnregistered share sale
8-K
Read ↗
Mar 2, 2020
Annual report
10-K
Read ↗
Mar 2, 2020
Results announced
8-K
Read ↗
Jan 10, 2020
Material agreementNew debt
8-K
Read ↗
Nov 14, 2019
Material agreement
8-K
Read ↗
Nov 5, 2019
Quarterly report
10-Q
Read ↗
Nov 5, 2019
Results announced
8-K
Read ↗
Sep 13, 2019
Material agreement
8-K
Read ↗
Aug 7, 2019
Results announced
8-K/A
Read ↗
Aug 6, 2019
Quarterly report
10-Q
Read ↗
Aug 6, 2019
Results announced
8-K
Read ↗
Jul 17, 2019
Executive or director change
8-K
Read ↗
May 7, 2019
Quarterly report
10-Q
Read ↗
May 7, 2019
Results announced
8-K
Read ↗
May 7, 2019
Shareholder vote
8-K
Read ↗
Mar 18, 2019
Executive or director change
8-K
Read ↗
Mar 5, 2019
Annual report
10-K
Read ↗
Mar 5, 2019
Results announced
8-K
Read ↗
Feb 8, 2019
Quarterly report
10-Q/A
Read ↗
Nov 21, 2018
Material agreement
8-K
Read ↗
Nov 7, 2018
Executive or director change
8-K
Read ↗
Nov 1, 2018
Quarterly report
10-Q
Read ↗
Nov 1, 2018
Results announced
8-K
Read ↗
Sep 21, 2018
Material agreement
8-K
Read ↗
Sep 18, 2018
Material agreement
8-K
Read ↗
Sep 13, 2018
Material agreement
8-K
Read ↗
Aug 6, 2018
Quarterly report
10-Q
Read ↗
Aug 6, 2018
Results announced
8-K
Read ↗
Aug 1, 2018
Executive or director change
8-K
Read ↗
Jun 1, 2018
Executive or director changeMaterial agreement
8-K
Read ↗
May 18, 2018
Material agreement
8-K
Read ↗
May 10, 2018
Quarterly report
10-Q
Read ↗
May 10, 2018
Results announced
8-K
Read ↗
May 4, 2018
Shareholder vote
8-K
Read ↗
Mar 5, 2018
Annual report
10-K
Read ↗
Mar 5, 2018
Results announced
8-K
Read ↗
Jan 17, 2018
Executive or director change
8-K
Read ↗
Dec 14, 2017
Material agreement
8-K
Read ↗
Nov 1, 2017
Quarterly report
10-Q
Read ↗
Nov 1, 2017
Results announced
8-K
Read ↗
Aug 14, 2017
Quarterly report
10-Q
Read ↗
Aug 14, 2017
Results announced
8-K
Read ↗
Jul 14, 2017
Material agreementNew debt
8-K
Read ↗
May 15, 2017
Quarterly report
10-Q
Read ↗
May 15, 2017
Results announced
8-K
Read ↗
May 8, 2017
Shareholder vote
8-K
Read ↗
Mar 16, 2017
Annual report
10-K
Read ↗
Mar 16, 2017
Results announced
8-K
Read ↗
Nov 22, 2016
Material agreementUnregistered share sale
8-K
Read ↗
Nov 7, 2016
Quarterly report
10-Q
Read ↗
Nov 7, 2016
Results announced
8-K
Read ↗

Source: Fate Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on FATE

Related datasets